chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in her chest while breathing in; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain in her chest while breathing in) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 031L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LINACLOTIDE (LINZESS) and SUCRALFATE (CARAFATE) for Gastrointestinal disorder NOS, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced CHEST PAIN (pain in her chest while breathing in). At the time of the report, CHEST PAIN (pain in her chest while breathing in) outcome was unknown.            Treatment include extra strength Tylenol.   This case was linked to MOD-2021-033826 (Patient Link).
tested positive for Covid; tested positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 50 year-old male patient received bnt162b2 (BNT162B2), administration date Jan2021 (Batch/Lot number: unknown) as dose 2, single and administration date Jan2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "type II diabetic" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for Covid". The event "tested positive for covid" and "tested positive for covid" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. The patient stated he was currently at the doctor's office waiting to be seen. The patient just tested positive for Covid. He had had the first two Pfizer vaccine back in Jan2021. The patient confirmed he was asking how to participate in clinical trials for SARS-Cov2 protease inhibitor, oral.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt recvd 3 doses of Engerix-B 14OCT91 it was determined that pt did not respond to vax series;
Client "broke out" into widespread rash on upper torso one hour after receiving FLUZONE.  Client took CLARITIN - applied topical cream and arrived at hospital ER at 4:45 PM-  She was stable- given prescription for PREDNISONE 20 mg BID x 3 days every 6 hours.
Left side of neck has developed swelling along lymph nodes. Went to Primary care Doctor. Saw her Nurse Practitioner on 3/3/21. Her nurse practitioner ordered Ultrasound Carotid Doppler Bilateral tests.  Radiology said Covid 19 vaccine research is showing some patients getting side effects of swelling of lymph nodes. Asked which arm I received vaccine in (left) same side as neck swelling and when I received first dose (2/08/2021).
Pt experienced tachycardia and severe dizziness and associated nausea.  BP 133/78, HR 94, sat 100.  Symptoms passed after 10 minutes of observation.  Sent patient home per her request.
Patient passed out while sitting down during 15 minute observation period and hit his face/nose.  EMS was called and the patient passed out a second time when EMS tried to stand him up.  Per EMS it is thought the reaction was vasovagal in nature.
7x8 cm lt deltoid erythema/edema/heat/pain @ inject site;
Breakthrough case after vaccination. C/O runny nose, loss of taste/smell, headache, and congestion onset 1/21/2022.
Itching all over body. Swelling on the entire left side of my body. Lasted 24 hours after injection.
Pt. received Moderna on 8/18/21.  Pt. stated he did not receive a covid vaccine.  After giving vaccine, electronic record was checked and pt. received J & J on 4/10/21.
I am a post-menopausal woman, who has not has a menstrual cycle since 2019 (and only had one period in all of 2019). Just over a week after my second Pfizer injection, I had a six day, regular-flow period.
Seven days post vaccine, a two inch diameter around the injection site became inflamed, red, swollen, hot to the touch, and itchy.
Received dose 2hours post dose, itching throat, ears. facial swelling. Bendryl 50mg taken. Symptoms continued for the day of shot and day after shot. Day 2 additional Bendryl total 200mg taken before relief of symptoms. My PCP is aware of reaction and will place allergy on chart.
The patient complained of itching skin and a scratchy throat.  She stated she has a nut allergy and was anxious.  She has medication to take for allergic in purse and wishes to leave and go to work. She had no edema to throat or mouth. Nurse checked vital signs and lungs were clear. This was discussed with the manager.
pain in right breast/some pain in left breast too; experiencing shortness of breath all day; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (pain in right breast/some pain in left breast too) and DYSPNOEA (experiencing shortness of breath all day) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (pain in right breast/some pain in left breast too) and DYSPNOEA (experiencing shortness of breath all day). At the time of the report, BREAST PAIN (pain in right breast/some pain in left breast too) and DYSPNOEA (experiencing shortness of breath all day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment medications were reported. No concomitant medications were reported.
Patient came in for Adult series booster 30mcg/.3ml and was administered 0.3ml of undiluted pediatric dose.  (~43mcg)
Client was given her pfizer booster 10 days too soon. Second pfizer was given 5/20/21 and booster was given today 11/10/21. The client had no adverse reactions while here at the clinic 30 min. after booster dose and was okay to leave clinic.
Within 3-4 hours post vax, the pt vomited, felt sluggish, dizzy, experienced abdominal pain. Symptoms lasted 24 hours.
JOINT ACHE; HEADACHE; FEVER OF 101.2 F; FATIGUE; NUMBING OF HAND; TINGLING OF HAND; DIARRHEA; SORE ARM AT THE INJECTION SITE; MUSCLE ACHE; BODY ACHE; RASH/ REDNESS AROUND THE TAPE; PALE; FEELING COLD BUT WHEN TOUCH FEELS HOT; EYE IS SO HOT; EXPIRED VACCINE USED; This spontaneous report received from a consumer concerned a 32 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had no health conditions. The patient experienced hives when treated with amoxicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: 21-SEP-2021) dose was not reported, administered on 21-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-SEP-2021, the patient experienced expired vaccine used. On 22-SEP-2021, the patient experienced body ache. On 22-SEP-2021, the patient experienced rash/ redness around the tape. On 22-SEP-2021, the patient experienced pale. On 22-SEP-2021, the patient experienced feeling cold but when touch feels hot. On 22-SEP-2021, the patient experienced eye is so hot. On 22-SEP-2021, the patient experienced joint ache. On 22-SEP-2021, the patient experienced headache. On 22-SEP-2021, the patient experienced fever of 101.2 f. On 22-SEP-2021, the patient experienced fatigue. On 22-SEP-2021, the patient experienced numbing of hand. On 22-SEP-2021, the patient experienced tingling of hand. On 22-SEP-2021, the patient experienced diarrhea. On 22-SEP-2021, the patient experienced sore arm at the injection site. On 22-SEP-2021, the patient experienced muscle ache. Laboratory data included: Body temperature (NR: not provided) 101.2 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever of 101.2 f, headache, fatigue, diarrhea, body ache, sore arm at the injection site, rash/ redness around the tape, pale, numbing of hand, muscle ache, joint ache, tingling of hand, eye is so hot, and feeling cold but when touch feels hot, and the outcome of expired vaccine used was not reported. This report was non-serious.
pt recv vax 27MAY98 & 29MAY98 pt devel nonspecific rash (few scattered papules only on trunk), & itching;ER or MD visit was required on 5JUN98;
Patient developed hives, swelling around her eyes, itching several hours after receiving meningococcal B vaccine.
Toward the end of March after the second vaccine I developed a fine rash on my chest, neck, and upper arms. I took Benadryl but still have the rash to date. Mild itch
third dose administered on 25-MAR-2004; second dose administered on 25-jul-2003; This spontaneous report was received from a physician via an immunization record from a case in litigation for quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (2303USA000366) and concerns an approximately 4-week-old female patient. The patient's concurrent conditions, medical history and concomitant medications were not provided.  On 23-JUN-2003, 25-JUL-2003 and on 25-MAR-2004, the patient was vaccinated with the first, second and third dose respectively of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (lot #, expiry date, route of administration and anatomical location were not provided) for prophylaxis. This was considered an inappropriate schedule of vaccine administered.   This is one of four reports regarding the same patient.; Sender's Comments:  US-009507513-2305USA005506: US-009507513-2303USA000366: US-009507513-2305USA005504:
Large area of erythema, site of inject was warm to touch w/in mimutes of inject; cold compresses were applied;
patient experienced a Vasovagal episode after feeling lightheaded. But 15 minutes later she did not regain consciousness.  EMS was notified.  Patient was observed on site for 30 minutes then released. Possible Conversion disorder
booster; Arthritic pain; Knee/hip arthritis; worse; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) at the age of 68 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "torn meniscus" (unspecified if ongoing), notes: I did have a torn meniscus 10 yrs ago. Concomitant medication(s) included: GABAPENTIN taken for insomnia (ongoing). Vaccination history included: Bnt162b2 (DOSE 1), for Covid-19 immunization, reaction(s): "Painful knee pain"; Bnt162b2 (DOSE 1, Note: AE term: Joint inflammation, Onset date: 02Apr2021, Seriousness criteria: Persistent/ Significant disability/Incapacity, AE required visit to: Physician office visit checked, AE outcome: not recovered, Treatment: Yes checked, If yes details: Rx Taking Pain and Cortisone shots), for Covid-19 immunization, reaction(s): "Joint Inflammation"; Covid-19 vaccine (Dose:2, Manufacture Unknown), for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset Oct2021, outcome "unknown", described as "booster"; ARTHRALGIA (non-serious) with onset 2021, outcome "not recovered", described as "Arthritic pain"; ARTHRITIS (non-serious) with onset 2021, outcome "not recovered", described as "Knee/hip arthritis"; CONDITION AGGRAVATED (non-serious) with onset 2021, outcome "unknown", described as "worse". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Prior Vaccinations was none. Vaccination Facility Type was reported as Pharmacy or Drug Store. 2 days after patient first vaccination for COVID 19 developed painful knee pain. It got worse after the booster in Oct. Patient never had persistent arthritic pain before this year and have a torn meniscus 10 years ago but it healed it seems that patent developed acute knee/hip arthritis after the vaccination and it persists.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from an RN with no past medical history or known allergies who on 8/19/00 was vaccinated with pneumococcal vaccine 23 polyvalent. There was no concomitant medication. Subsequently, the nurse developed a pain, swelling and redness at the injection site. The pt sough unspecified medical attention. Additional information has been reported.
Patient states that around 24 hours after she received the second Pfizer covid vaccine she started to experience swelling in the lymph nodes of her left armpit.  Three days later she is still having some pain and swelling and redness on the left side.
Information has been received from a registered nurse concerning a 5 day old patient who on 26-MAR-2008 was vaccinated with a dose of Rotateq.  No adverse experience was related to this event.  There was no product quality complaint.  Additional information has been requested.
Redness, swelling, pain, itching to left upper extremity along with numbness and tingling in left arm. Onset of symptoms on 8-4-16 at 2:00 PM.
Some pressure on head; Left arm was extremely swollen; Could not even stretch out arm; Uncomfortable to sleep; Very sore arm/ Pain in left arm pit; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Some pressure on head), MYALGIA (Very sore arm/ Pain in left arm pit), PERIPHERAL SWELLING (Left arm was extremely swollen), LIMB DISCOMFORT (Could not even stretch out arm) and INSOMNIA (Uncomfortable to sleep) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (Some pressure on head), MYALGIA (Very sore arm/ Pain in left arm pit), PERIPHERAL SWELLING (Left arm was extremely swollen), LIMB DISCOMFORT (Could not even stretch out arm) and INSOMNIA (Uncomfortable to sleep). At the time of the report, HEAD DISCOMFORT (Some pressure on head), PERIPHERAL SWELLING (Left arm was extremely swollen), LIMB DISCOMFORT (Could not even stretch out arm) and INSOMNIA (Uncomfortable to sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
A 9 year old male received 0.2ml of the 12+ Pfizer vaccine. Patient is in his usual state of health and has not had any side effects.
Saturday morning I woke up with high fever, terrible head cold, headache, dizziness,very weak, and no appetite. I was unable to rest my head where I pleased because the pain was excruciating to make simple movement. I wasn't able to sleep comfortable for several nights because it hurt the back of my neck and spine when I tried to move my neck. I was left to nursing a stiff neck after the fever went and hot pads to move my neck again and sleep.
Left arm injection site pain started 20 minutes post-injection, and progressed to  left arm pain and erythema from neck to hand, lightheadedness and nausea by the next day. Patient sought medical care within 24 hours of this injection. She was treated with ZOFRAN, fluids, and observation in the clinic. Symptoms improved and she was able to return home. (Vaccine given on 2-15-2018 at mass vaccination clinic on campus: Bexsero #2).
Developed marble sized lump near Left side collar bone. Was seen in office 10/7/20. US of neck was ordered. Swollen painful lymph node the next day
Admitted for COVID. Completed vaccine series Aug 2021. Treated with O2, steroids, zinc, vit-c, cefepime, vit-d, singulair. Weaned to RA and discharged home.
Extreme pain and swelling at injection site started within hours after getting first dose.  Most recently large cutaneous red blotch in area of injection extremely painful to touch.  Some fatigue and general feeling of malaise to today?s date.
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients' of unknown age and gender. The patients' pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date the patients' were vaccinated with improperly stored GARDASIL 9 (lot # L014415, expiry date 25-JUL-2017). Temperature was at minimum 22.5 F to maximum 34.7 F. The temperature excursion occurred from February thru 19-MAR-2016. Time frame was 98 hours cumulatively. There was no previous excursion. No adverse events were reported. No product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Swelling of vaccinated limb - reported by Mother of Child over the phone.  Administration of 200 mg ibuprofen every 4 hours.
Information has been received from a health professional concerning a female who was vaccinated intramuscularly with the first two doses of Gardasil. There was no concomitant medication. Subsequently the patient has not menstruated for 3 months. Physician decided to stop the third dose. Patient sought unspecified medical attention. Additional information has been requested.
Red/ hot arm  started the following morning. Still red and hot. Limited mobility in arm. Sore throat, aches, runny nose, headache, fatigue started the following morning and getting worse.
Fever (highest 100.5), headache, substantial muscle aches, rash..six days after shot several pustules on back of neck, left arm. 8 days later (today) still feeling prickly and dizzy but no longer all day dizziness.
Starting on 1/15, Severe headache, vomiting x3 days, hives all over body for 3 days. Injection site arm very itchy.
Had a Covid 19 exposer; Revaccination with different COVID-19 vaccine; Completed Moderna Covid 19 vaccine series. Had a Covid 19 exposer and went to a local pharmacy to get a Covid test and was inadvertantly given a Pfizer Covid 19 Vaccine dose; Inadvertantly given a Pfizer Covid 19 Vaccine dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE TO SARS-COV-2 (Had a Covid 19 exposer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (Completed Moderna Covid 19 vaccine series. Had a Covid 19 exposer and went to a local pharmacy to get a Covid test and was inadvertantly given a Pfizer Covid 19 Vaccine dose) and PRODUCT ADMINISTRATION ERROR (Inadvertantly given a Pfizer Covid 19 Vaccine dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (COMIRNATY) for COVID-19 prophylaxis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. and dose of TOZINAMERAN (COMIRNATY) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (Had a Covid 19 exposer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (Completed Moderna Covid 19 vaccine series. Had a Covid 19 exposer and went to a local pharmacy to get a Covid test and was inadvertantly given a Pfizer Covid 19 Vaccine dose) and PRODUCT ADMINISTRATION ERROR (Inadvertantly given a Pfizer Covid 19 Vaccine dose). At the time of the report, EXPOSURE TO SARS-COV-2 (Had a Covid 19 exposer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (Completed Moderna Covid 19 vaccine series. Had a Covid 19 exposer and went to a local pharmacy to get a Covid test and was inadvertantly given a Pfizer Covid 19 Vaccine dose) and PRODUCT ADMINISTRATION ERROR (Inadvertantly given a Pfizer Covid 19 Vaccine dose) outcome was unknown.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication was provided. No treatment medication was provided. It was reported that patient had completed Moderna Covid 19 vaccine series. Had a Covid 19 exposer and went to a local to get a Covid test and was inadvertently given a Pfizer Covid 19 Vaccine dose. There were no data available on the interchangeability of the Pfizer-BioNTech COVID-19 Vaccine or COMIRNATY (COVID-19 Vaccine, mRNA) with other authorized COVID-19 vaccines to complete the primary vaccination series or booster dose.
Patient received the third dose of HPV and her second dose of Hepatitis A yesterday, April 3, 2008, around 3:30 p.m.  She was feeling totally fine, no problems.  On Friday, April 4, 2008, I received a call from her school to pick her up due to vomiting and lower back pain. She left for school feeling fine and I received the call about one hour later-8:45a.m.
Around 20 hours  after vaccination appeared  (erythema and rash with pruritus on trunk and upper extremities ), TX : Benadryl one tablet every 12 hours.
Raised, hard, itchy rash with red bumps, soreness, and warmth. Pt. had felt flushed, temp. 9/30/10 4:13 pm = 97.5, Rx for doxycycline.
Vaccinia inoculation in L upper arm; rash surrounding site approx 10cm, vesicles on R hand and forearm, L forearm, bilateral legs possibly d/t self-inoculation, possibly systemic response.
Information has been received from a female patient of unknown age via email referring to herself. The patient had a carbohydrate digestive disorder that had as one of its symptoms, hypoglycemia. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX23 injection, (lot number, expiry date, dose and route were not reported). Within ten minutes of receiving this injection, the patient began having a hypoglycemic reaction. The outcome of the event was unknown. The patient wanted to know what sugars were involved in the polysaccharide of the vaccine to help her better understanding the triggers to her carbohydrate disorder. Additional information has been requested.
feeling itchy all over; nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (feeling itchy all over) and NAUSEA (nausea) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced NAUSEA (nausea). On 28-Mar-2021, the patient experienced PRURITUS (feeling itchy all over). On 30-Mar-2021, NAUSEA (nausea) had resolved. On 31-Mar-2021, PRURITUS (feeling itchy all over) had resolved.            Concomitant product use was not provided by the reporter.  It was reported that the patient's husband called the pharmacy and was prescribed treatment with ondansetron.  Reportedly, the patient consented to be contacted by phone, home or cell.